Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Mast cells might contribute to hair loss by causing skin thickening.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Micrografts promote hair growth in androgenetic alopecia treatment.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Male hormones control a specific gene in hamster skin, with different hormones having varying effects.

Finasteride reduces melanin production, possibly treating hyperpigmentation and melanoma, but needs more safety research.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Hair loss gene linked to prostate issues.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Finasteride boosts stem cell signals for hair growth.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Minocycline may cause hair loss by increasing DHT levels, but finasteride can help counteract this effect.

Androgens increase EPO production, finasteride doesn't significantly impact it.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

A herbal extract may help treat certain types of hair loss by reducing a specific gene's activity.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.